Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

Author: Mayer Doris   Chantelau Ernst  

Publisher: Informa Healthcare

ISSN: 1381-3455

Source: Archives of Physiology and Biochemistry, Vol.116, Iss.2, 2010-05, pp. : 73-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content